Pulmonx (LUNG) Stock Chart & Stock Price History → #1 Crypto of 2024 (From True Market Insiders) (Ad) Free LUNG Stock Alerts $7.43 +0.01 (+0.13%) (As of 04:00 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pulmonx Stock Price Performance5 Day Performance-5.83%1 Month Performance-16.98%3 Month Performance-41.59%6 Month Performance-13.60%Year-To-Date Performance-41.73%1 Year Performance-35.73% Receive LUNG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market Insiders#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 LUNG Stock Chart for Wednesday, April, 17, 2024 LUNG Chart by TradingView Pulmonx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/16/2024$7.47$7.42-0.67%$7.57$7.34268,313 shs$285.97 million04/15/2024$7.89$7.47-5.32%$7.91$7.38275,813 shs$287.89 million04/12/2024$8.35$7.89-5.51%$8.25$7.721.48 million shs$304.06 million04/11/2024$8.32$8.35+0.36%$8.40$8.21147,858 shs$321.81 million04/10/2024$8.65$8.32-3.82%$8.46$8.16271,315 shs$320.65 million04/09/2024$8.39$8.65+3.10%$8.70$8.36653,663 shs$333.37 million Get the Latest News and Ratings for LUNG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter. 04/08/2024$8.24$8.39+1.82%$8.46$8.14245,731 shs$323.35 million04/05/2024$7.86$8.24+4.83%$8.25$7.77277,526 shs$317.57 million04/04/2024$7.95$7.86-1.13%$8.07$7.78605,883 shs$302.92 million04/03/2024$8.51$7.95-6.58%$8.70$7.88321,735 shs$306.39 million04/02/2024$9.13$8.51-6.79%$9.02$8.36649,574 shs$327.98 million04/01/2024$9.27$9.13-1.51%$9.29$9.00286,252 shs$351.87 million03/29/2024$9.27$9.27$9.46$9.12943,295 shs$357.27 million03/28/2024$9.11$9.27+1.76%$9.46$9.12943,295 shs$357.27 million03/27/2024$8.99$9.11+1.33%$9.17$9.03716,721 shs$351.10 million03/26/2024$8.93$8.99+0.67%$9.18$8.93540,854 shs$346.48 million03/25/2024$9.21$8.93-3.04%$9.28$8.92345,279 shs$344.16 million03/22/2024$9.39$9.21-1.92%$9.54$8.92591,322 shs$354.95 million03/21/2024$9.53$9.39-1.47%$9.71$9.36377,028 shs$361.89 million03/20/2024$9.32$9.53+2.25%$9.59$9.17554,152 shs$367.29 million03/19/2024$8.83$9.32+5.55%$9.32$8.74476,655 shs$359.19 million03/18/2024$8.95$8.83-1.34%$8.96$8.74490,764 shs$340.31 million03/15/2024$8.80$8.95+1.70%$9.02$8.681.13 million shs$344.93 million03/14/2024$8.78$8.80+0.23%$8.96$8.62433,639 shs$339.13 million03/13/2024$8.90$8.78-1.35%$8.98$8.74281,624 shs$338.36 million03/12/2024$8.71$8.90+2.18%$9.02$8.71317,856 shs$343.01 million03/11/2024$9.09$8.71-4.18%$9.14$8.64261,637 shs$335.68 million03/08/2024$8.80$9.09+3.30%$9.33$8.90426,242 shs$350.33 million03/07/2024$8.85$8.80-0.56%$9.06$8.79261,834 shs$339.15 million03/06/2024$9.00$8.85-1.67%$9.12$8.77369,470 shs$341.08 million03/05/2024$9.26$9.00-2.81%$9.45$8.94384,267 shs$346.86 million03/04/2024$9.30$9.26-0.43%$9.41$9.09413,231 shs$356.88 million03/01/2024$9.22$9.30+0.87%$9.52$8.99517,538 shs$358.42 million02/29/2024$9.36$9.22-1.50%$9.74$9.081.18 million shs$353.22 million02/28/2024$10.12$9.36-7.51%$10.07$9.341.78 million shs$358.58 million02/27/2024$10.39$10.12-2.60%$10.48$10.08321,806 shs$387.70 million02/26/2024$10.81$10.39-3.89%$11.10$10.27450,604 shs$398.04 million02/23/2024$11.86$10.81-8.85%$11.73$10.561.35 million shs$414.13 million02/22/2024$14.50$11.86-18.21%$14.20$11.622.16 million shs$454.36 million02/21/2024$14.41$14.50+0.62%$14.52$14.32823,272 shs$555.50 millionThe 1,000X Crypto Playbook (Ad)Chris Rowe has created a “Crypto Playbook” that anyone can follow… potentially turning small investments into pers#1 Crypto for 2024, completely FREE.02/20/2024$14.32$14.41+0.63%$14.60$14.18654,259 shs$552.05 million02/19/2024$14.32$14.32$14.50$14.26309,100 shs$548.60 million02/16/2024$14.58$14.32-1.78%$14.50$14.26309,166 shs$548.60 million02/15/2024$14.65$14.58-0.48%$14.84$14.38224,326 shs$558.53 million02/14/2024$14.27$14.65+2.66%$14.70$14.26176,022 shs$561.21 million02/13/2024$14.65$14.27-2.59%$14.58$14.20367,730 shs$546.68 million02/12/2024$14.25$14.65+2.81%$14.73$14.25768,866 shs$561.24 million02/09/2024$14.32$14.25-0.49%$14.80$14.23319,635 shs$548.57 million02/08/2024$14.48$14.32-1.10%$14.50$14.25429,911 shs$548.60 million02/07/2024$14.46$14.48+0.14%$14.53$14.25194,795 shs$554.73 million02/06/2024$14.31$14.46+1.05%$14.68$14.25361,978 shs$553.96 million02/05/2024$14.26$14.31+0.35%$14.58$13.95332,454 shs$548.22 million02/02/2024$14.29$14.26-0.21%$14.50$13.91507,637 shs$546.30 million02/01/2024$13.28$14.29+7.61%$14.47$13.26319,807 shs$547.45 million01/31/2024$13.20$13.28+0.61%$14.08$13.07476,807 shs$508.76 million01/30/2024$13.72$13.20-3.79%$13.68$13.13200,110 shs$505.69 million01/29/2024$13.40$13.72+2.39%$13.75$13.23145,089 shs$525.61 million01/26/2024$13.39$13.40+0.07%$13.62$13.28179,000 shs$513.35 million01/25/2024$13.18$13.39+1.59%$13.45$13.18170,815 shs$512.94 million01/24/2024$13.52$13.18-2.51%$13.78$13.11233,695 shs$504.93 million01/23/2024$13.48$13.52+0.30%$13.75$13.27297,103 shs$517.95 million01/22/2024$13.01$13.48+3.61%$13.53$13.11362,548 shs$516.42 million01/19/2024$12.83$13.01+1.40%$13.33$12.65351,322 shs$498.41 million01/18/2024$12.72$12.83+0.86%$12.89$12.59163,983 shs$491.52 million01/17/2024$12.75$12.72-0.24%$12.85$12.48150,365 shs$487.30 million01/16/2024$12.73$12.75+0.16%$12.88$12.50217,864 shs$488.45 million Related Companies: Cerus Stock Chart Lyra Therapeutics Stock Chart Fractyl Health Stock Chart Sight Sciences Stock Chart Tactile Systems Technology Stock Chart Anika Therapeutics Stock Chart AVITA Medical Stock Chart AngioDynamics Stock Chart Inovio Pharmaceuticals Stock Chart Surmodics Stock Chart Receive LUNG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUNG) was last updated on 4/17/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersThe “Perfect Storm” for GoldGold Safe ExchangeIRS Loophole Gives Americans An Escape From InflationBirch GoldCould Bitcoin Literally FORCE This Crypto To Rocket Up?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsNew Trump BombshellThe Freeport SocietyAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.